CD33 and breast carcinoma: The potential correlation between Mo-MDSCs and CTCs was hitherto unexplored in breast cancer patients, although it has been proposed that MDSCs (CD11b+CD33+Lin−HLA-DR− cells) may correlate with CTCs [16].